Lead development: validation and application of high throughput screening for determination of pharmacokinetic parameters for enzyme inhibitors.
An approach utilizing robotics (automation) for the rapid and reliable determination of protease inhibitor concentration in rat plasma samples is described. The bioassay protocol using an immobilized peptide substrate allows high sample throughput, compatible with parallel synthesis/SAR development strategy.